Fundraising Fox㈜진씨커
2 known investors
Find your way into ㈜진씨커
Sign up to see every warm intro you have to ㈜진씨커
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ㈜진씨커 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GeneCker develops CRISPR/Cas9-based liquid biopsy diagnostics for early cancer detection, analyzing low-frequency circulating tumor DNA (ctDNA) mutations in blood. The company serves the in vitro diagnostics market with ultra-sensitive genomic testing for precision cancer diagnosis.
Founders & leadership
SY
Seonghyeok YeCo-Founder & Co-CEO
JW
Junseok W. HurCo-Founder & Co-CEO
KC
Kyung-Hak ChoiVP
IL
In-Seon LeeLead, Product Development Team & Molecular Diagnostics Laboratory
Investors · 2
Frequently asked questions
- What does ㈜진씨커 do?
- GeneCker develops CRISPR/Cas9-based liquid biopsy diagnostics for early cancer detection, analyzing low-frequency circulating tumor DNA (ctDNA) mutations in blood. The company serves the in vitro diagnostics market with ultra-sensitive genomic testing for precision cancer diagnosis.
- Who are ㈜진씨커's investors?
- ㈜진씨커's investors include SBI Investment Korea Co. Ltd., Snickpick Investment.